MGI and Xihu Yiming have formed a strategic partnership to jointly launch a high-throughput immune health monitoring solution
According to the official WeChat account of MGI, on October 24th, at the 20th International Genomics Conference, Xihu Yiming Biotechnology Co., Ltd. and MGI announced a deep strategic cooperation, and the two parties will jointly launch a high-throughput immune health monitoring program aimed at the general consumer, exploring more application scenarios in areas such as anti-infection immunity, allergies, food intolerance, bodily aging, and disease warning
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments